The new threats of Gram positive pathogens: re-emergence of things past.
作者信息
Howe R A, Brown N M, Spencer R C
机构信息
Public Health Laboratory, Bristol Royal Infirmary.
出版信息
J Clin Pathol. 1996 Jun;49(6):444-9. doi: 10.1136/jcp.49.6.444.
Abstract
摘要
相似文献
1
The new threats of Gram positive pathogens: re-emergence of things past.革兰氏阳性病原体的新威胁：往昔之事的再度浮现。
J Clin Pathol. 1996 Jun;49(6):444-9. doi: 10.1136/jcp.49.6.444.
2
Iron acquisition by Gram-positive bacterial pathogens.革兰氏阳性细菌病原体获取铁的过程。
Microbes Infect. 2002 Sep;4(11):1149-56. doi: 10.1016/s1286-4579(02)01640-4.
3
Accentuate the (Gram) positive.
J Mol Med (Berl). 2010 Feb;88(2):93-5. doi: 10.1007/s00109-010-0598-1. Epub 2010 Feb 20.
4
A simple model host for identifying Gram-positive virulence factors.一种用于鉴定革兰氏阳性菌毒力因子的简单模式宿主。
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10892-7. doi: 10.1073/pnas.191378698. Epub 2001 Sep 4.
5
Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications.革兰阳性病原体对补体的抑制：分子机制及治疗意义。
J Mol Med (Berl). 2010 Feb;88(2):115-20. doi: 10.1007/s00109-009-0572-y.
6
[Update on antibiotic resistance in Gram-positive bacteria].[革兰氏阳性菌抗生素耐药性的最新情况]
Enferm Infecc Microbiol Clin. 2017 Jan;35 Suppl 1:2-8. doi: 10.1016/S0213-005X(17)30028-9.
7
[KITASAMYCIN].[北里霉素]
Presse Med (1893). 1963 Nov 2;71:2198-9.
8
9
Mechanisms of action of newer antibiotics for Gram-positive pathogens.新型抗生素对革兰氏阳性病原体的作用机制。
Lancet Infect Dis. 2005 Apr;5(4):209-18. doi: 10.1016/S1473-3099(05)70051-7.
10
[Microbiological and chemotherapeutic study of the antibiotic mutabilicin].[抗生素变链菌素的微生物学与化疗研究]
Antibiotiki. 1967 May;12(5):404-6.
引用本文的文献
1
Current guidelines for the treatment and prevention of nosocomial infections.医院感染治疗与预防的现行指南。
Drugs. 1999 Jul;58(1):51-67. doi: 10.2165/00003495-199958010-00005.
本文引用的文献
1
QUANTITATIVE ACTION OF PENICILLIN INHIBITOR FROM PENICILLIN-RESISTANT STRAINS OF STAPHYLOCOCCI.来自耐青霉素葡萄球菌菌株的青霉素抑制剂的定量作用
Science. 1945 Aug 31;102(2644):221-3. doi: 10.1126/science.102.2644.221.
2
Studies on the virulence of bacteriophage-infected strains of Corynebacterium diphtheriae.白喉棒状杆菌噬菌体感染菌株的毒力研究。
J Bacteriol. 1951 Jun;61(6):675-88. doi: 10.1128/jb.61.6.675-688.1951.
3
Diphtheria control in the 1960's.
R Soc Health J. 1962 May-Jun;82:158-64. doi: 10.1177/146642406208200370.
4
Methicillin-resistant staphylococci.耐甲氧西林葡萄球菌
J Clin Pathol. 1961 Jul;14(4):385-93. doi: 10.1136/jcp.14.4.385.
5
Genetics and molecular biology of beta-lactam-resistant pneumococci.β-内酰胺耐药肺炎球菌的遗传学与分子生物学
Microb Drug Resist. 1995 Spring;1(1):29-34. doi: 10.1089/mdr.1995.1.29.
6
Clinical and microbiological characteristics of severe group A streptococcus infections and streptococcal toxic shock syndrome.A组链球菌严重感染及链球菌中毒性休克综合征的临床和微生物学特征
Clin Infect Dis. 1995 Aug;21(2):333-40. doi: 10.1093/clinids/21.2.333.
7
Infections due to penicillin-resistant pneumococci. Clinical, epidemiologic, and microbiologic features.耐青霉素肺炎球菌感染。临床、流行病学及微生物学特征。
Arch Intern Med. 1993 Jun 14;153(11):1301-10.
8
Penicillin-binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation for the inoculum effect.不同生长阶段青霉素结合蛋白的表达决定了青霉素在体外和体内的疗效：对接种量效应的一种解释。
J Infect Dis. 1993 Jun;167(6):1401-5. doi: 10.1093/infdis/167.6.1401.
9
Infective endocarditis due to nontoxigenic Corynebacterium diphtheriae: report of seven cases and review.非产毒白喉棒状杆菌所致感染性心内膜炎：7例报告及文献复习
Clin Infect Dis. 1993 Feb;16(2):271-5. doi: 10.1093/clind/16.2.271.
10
Recombinant tetravalent group A streptococcal M protein vaccine.重组A群链球菌M蛋白四价疫苗
J Immunol. 1993 Aug 15;151(4):2188-94.
Zotero 插件